Nanomedicine Approaches for Autophagy Modulation in Cancer Therapy
Small Science · 2025-06 · 5 (6)
DOI: 10.1002/smsc.202400607 ↗Kurz gefasst
Fachartikel in der Zeitschrift Small Science, online erschienen am 11.04.2025. Verfasst von Sohaib Mahri und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Molecular Medicine UC Davis Comprehensive Cancer Center University of California Davis Sacramento CA 95817 USA. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 480 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NIBIB NIH HHS, NIGMS NIH HHS.
Abstract (Originalsprache)
Cancer is a daunting global health problem with a steadily rising incidence. Despite the wide arsenal of current anticancer therapies, challenges such as drug resistance, tumor heterogeneity, poor targeting, and severe side effects often lead to suboptimal efficacy and poor patient outcomes, highlighting the need for innovative therapies. Autophagy modulation has emerged as an attractive approach to complement existing therapies. The dual role of autophagy in cancer promotion and suppression has inspired the development of new drugs and therapeutic strategies focusing on both inhibition and induction. Despite the promising results of current autophagy modulators in preclinical studies, challenges such as the lack of selectivity and potency, toxicity, poor pharmacokinetics, and inadequate tumor targeting continue to limit their successful clinical translation. Many of these challenges could be overcome using nanomedicine. This review explores recent advancements in nanomedicine strategies for autophagy modulation. Successful combination strategies leveraging nanoparticles and autophagy modulators in synergy with chemotherapy, immunotherapy, phototherapy, gene therapy, and other modalities are presented. Additionally, nanomaterials with intrinsic autophagy‐modulating capabilities, such as self‐assembling autophagy inhibitors, are discussed. Finally, limitations of autophagy modulators currently in clinical trials are discussed, and future perspectives on designing nanomedicine for successful clinical implementation are explored.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Biochemistry and Molecular Medicine UC Davis Comprehensive Cancer Center University of California Davis Sacramento CA 95817 USA.
- Department of Radiology University of California Davis Sacramento CA 95817 USA.
- Department of Otolaryngology, Head and Neck Surgery University of California Davis Sacramento CA 95817 USA.
- Division of Hematology/Oncology Department of Internal Medicine University of California Davis Sacramento CA 95817 USA.
ORCID-Profile: Yuanpei Li
Förderung
- NCI NIH HHS
- NIBIB NIH HHS
- NIGMS NIH HHS
- NIDCR NIH HHS
Zitieren
APA
Mahri, S., Villa, R., Shiau, Y. P., Tang, M., Racacho, K. J., Zong, Q., Chowdhury, S. I., Hua, T., Godinez, F., Birkeland, A., Lin, T. Y., & Li, Y. (2025). Nanomedicine Approaches for Autophagy Modulation in Cancer Therapy. Small Science, 5(6). https://doi.org/10.1002/smsc.202400607
Vancouver
Mahri S, Villa R, Shiau YP, Tang M, Racacho KJ, Zong Q, et al. Nanomedicine Approaches for Autophagy Modulation in Cancer Therapy. Small Science. 2025;5(6). doi:10.1002/smsc.202400607
BibTeX
@article{Mahri2025,
author = {Mahri, Sohaib and Villa, Rodolfo and Shiau, Ya-Ping and Tang, Menghuan and Racacho, Kelsey Jane and Zong, Qiufang and Chowdhury, Saiful Islam and Hua, Tan and Godinez, Felipe and Birkeland, Andrew and Lin, Tzu-Yin and Li, Yuanpei},
title = {Nanomedicine Approaches for Autophagy Modulation in Cancer Therapy},
journal = {Small Science},
year = {2025},
volume = {5},
number = {6},
doi = {10.1002/smsc.202400607}
}
EUVIMED